Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Position statement on defining and standardizing an oncoplastic approach to breast-conserving surgery in Canada.

Arnaout A, Ross D, Khayat E, Richardson J, Kapala M, Hanrahan R, Zhang J, Doherty C, Brackstone M.

Curr Oncol. 2019 Jun;26(3):e405-e409. doi: 10.3747/co.26.4195. Epub 2019 Jun 1.

2.

Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy.

Guidolin K, Yaremko B, Lynn K, Gaede S, Kornecki A, Muscedere G, BenNachum I, Shmuilovich O, Mouawad M, Yu E, Sexton T, PhD MD, Gelman N, Moiseenko V, Brackstone M, Lock M.

Curr Oncol. 2019 Jun;26(3):e334-e340. doi: 10.3747/co.26.4479. Epub 2019 Jun 1.

3.

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.

Hannouf MB, Zaric GS, Blanchette P, Brezden-Masley C, Paulden M, McCabe C, Raphael J, Brackstone M.

Pharmacogenomics J. 2019 May 27. doi: 10.1038/s41397-019-0089-x. [Epub ahead of print]

PMID:
31130722
4.

Intraoperative photoacoustic screening of breast cancer: a new perspective on malignancy visualization and surgical guidance.

Kosik I, Brackstone M, Kornecki A, Chamson-Reig A, Wong P, Araghi MH, Carson JJ.

J Biomed Opt. 2019 May;24(5):1-12. doi: 10.1117/1.JBO.24.5.056002.

PMID:
31111698
5.

Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients.

Mouawad M, Biernaski H, Brackstone M, Lock M, Yaremko B, Sexton T, Yu E, Dinniwell RE, Lynn K, Hajdok G, Prato FS, Thompson RT, Gelman N, Gaede S.

Radiother Oncol. 2019 Feb;131:60-65. doi: 10.1016/j.radonc.2018.11.020. Epub 2018 Dec 29.

PMID:
30773188
6.

TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.

Krstic M, Kolendowski B, Cecchini MJ, Postenka CO, Hassan HM, Andrews J, MacMillan CD, Williams KC, Leong HS, Brackstone M, Torchia J, Chambers AF, Tuck AB.

J Pathol. 2019 Jun;248(2):191-203. doi: 10.1002/path.5245. Epub 2019 Apr 8.

7.

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, Torres J, Marques M, Habyan SA, Bijian K, Amant F, Witcher M, Behbod F, McCaffrey L, Alaoui-Jamali M, Giannakopoulos NV, Brackstone M, Postovit LM, Del Rincón SV, Miller WH Jr.

Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.

8.

Appropriate treatment receipt after breast-conserving surgery.

Guidolin K, Lock M, Vogt K, McClure JA, Winick-Ng J, Vinden C, Brackstone M.

Curr Oncol. 2018 Dec;25(6):e545-e552. doi: 10.3747/co.25.4117. Epub 2018 Dec 1.

9.

A prospective intervention to improve happiness and reduce burnout in oncologists.

Clemons M, Mazzarello S, Pond G, Amir E, Asmis T, Berry S, Brackstone M, Brule S, Goodwin R, Hilton JF, Julião M, Nicholas G, Stewart DJ, Wheatley-Price P, Cholmsky L, Krentel A, Hutton B, Joy AA.

Support Care Cancer. 2019 Apr;27(4):1563-1572. doi: 10.1007/s00520-018-4567-5. Epub 2018 Nov 30.

PMID:
30506102
10.

Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections (NEPTUNE): A Randomized Controlled Trial.

Murphy PB, Knowles S, Chadi SA, Vogt K, Brackstone M, Koughnett JAV, Ott MC.

Ann Surg. 2019 Jul;270(1):38-42. doi: 10.1097/SLA.0000000000003111.

PMID:
30499799
11.

Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

Kim CS, Hannouf MB, Sarma S, Rodrigues GB, Rogan PK, Mahmud SM, Winquist E, Brackstone M, Zaric GS.

Curr Oncol. 2018 Oct;25(5):307-316. doi: 10.3747/co.25.4003. Epub 2018 Oct 31.

12.

Clinical utility of radioactive seed localization in nonpalpable breast cancer: A retrospective single institutional cohort study.

Aljohani B, Jumaa K, Kornecki A, Brackstone M.

Int J Surg. 2018 Dec;60:149-152. doi: 10.1016/j.ijsu.2018.11.004. Epub 2018 Nov 13.

PMID:
30439537
13.

KISS1/KISS1R in Cancer: Friend or Foe?

Guzman S, Brackstone M, Radovick S, Babwah AV, Bhattacharya MM.

Front Endocrinol (Lausanne). 2018 Aug 3;9:437. doi: 10.3389/fendo.2018.00437. eCollection 2018. Review.

14.

The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.

Noonan MM, Dragan M, Mehta MM, Hess DA, Brackstone M, Tuck AB, Viswakarma N, Rana A, Babwah AV, Wondisford FE, Bhattacharya M.

Oncotarget. 2018 Jul 10;9(53):30034-30052. doi: 10.18632/oncotarget.25682. eCollection 2018 Jul 10.

15.

Long-term oncological outcomes following emergency resection of colon cancer.

Wanis KN, Ott M, Van Koughnett JAM, Colquhoun P, Brackstone M.

Int J Colorectal Dis. 2018 Nov;33(11):1525-1532. doi: 10.1007/s00384-018-3109-4. Epub 2018 Jun 26.

PMID:
29946860
16.

The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study.

Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan PK, Hoch JS, Zaric GS.

Pharmacoecon Open. 2018 Sep;2(3):255-270. doi: 10.1007/s41669-017-0051-2.

17.

Patient-perceived barriers to radiation therapy for breast cancer.

Guidolin K, Lock M, Brackstone M.

Can J Surg. 2018 Apr;61(2):141-143.

18.

COX-2 induces oncogenic micro RNA miR655 in human breast cancer.

Majumder M, Dunn L, Liu L, Hasan A, Vincent K, Brackstone M, Hess D, Lala PK.

Sci Rep. 2018 Jan 10;8(1):327. doi: 10.1038/s41598-017-18612-3.

19.

Training Canadian surgeons in oncoplastic breast surgery: Where do we stand?

Khayat E, Brackstone M, Maxwell J, Hanrahan R, Richardson J, Kapala M, Arnaout A.

Can J Surg. 2017 Dec;60(6):369-371.

20.

Patient-perceived barriers to radiation therapy for breast cancer.

Guidolin K, Lock M, Brackstone M.

Can J Surg. 2017 Dec 1;61(1):15716. doi: 10.1503/cjs.015716. [Epub ahead of print]

PMID:
29171833
21.

Do Moderate Surgical Treatment Delays Influence Survival in Colon Cancer?

Wanis KN, Patel SVB, Brackstone M.

Dis Colon Rectum. 2017 Dec;60(12):1241-1249. doi: 10.1097/DCR.0000000000000857.

PMID:
29112559
22.

Training oncoplastic breast surgeons: the Canadian fellowship experience.

Maxwell J, Arnaout A, Hanrahan R, Brackstone M.

Curr Oncol. 2017 Oct;24(5):e394-e402. doi: 10.3747/co.24.3554. Epub 2017 Oct 25.

23.

The clinical significance of occult gynecologic primary tumours in metastatic cancer.

Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan PK, Hoch JS, Zaric GS.

Curr Oncol. 2017 Oct;24(5):e368-e378. doi: 10.3747/co.24.3594. Epub 2017 Oct 25.

24.

Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer.

Brackstone M, Palma D, Tuck AB, Scott L, Potvin K, Vandenberg T, Perera F, D'Souza D, Taves D, Kornecki A, Muscedere G, Chambers AF.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):769-776. doi: 10.1016/j.ijrobp.2017.06.005. Epub 2017 Jun 20.

PMID:
28870785
25.

Physician "out of office" alert: does it work?

Clemons M, Joy AA, Hilton J, Arnaout A, Brackstone M, Wheatley-Price P, Stober C, Dinniwell R, Mazzarello S, da Costa M, Hutton B.

Curr Oncol. 2017 Jun;24(3):e176-e179. doi: 10.3747/co.24.3548. Epub 2017 Jun 27. No abstract available.

26.

G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance.

Blake A, Dragan M, Tirona RG, Hardy DB, Brackstone M, Tuck AB, Babwah AV, Bhattacharya M.

Sci Rep. 2017 Apr 19;7:46525. doi: 10.1038/srep46525.

27.

The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study.

Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan PK, Hoch JS, Zaric GS.

Cancer Res Treat. 2018 Jan;50(1):183-194. doi: 10.4143/crt.2016.532. Epub 2017 Mar 21.

28.

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients.

Jacobs C, Clemons M, Mazzarello S, Hutton B, Joy AA, Brackstone M, Freedman O, Vandermeer L, Ibrahim M, Fergusson D, Hilton J.

Support Care Cancer. 2017 Jun;25(6):1881-1886. doi: 10.1007/s00520-017-3580-4. Epub 2017 Jan 27.

PMID:
28127659
29.

The effect of surgery type on survival and recurrence in very young women with breast cancer.

Quan ML, Paszat LF, Fernandes KA, Sutradhar R, McCready DR, Rakovitch E, Warner E, Wright FC, Hodgson N, Brackstone M, Baxter NN.

J Surg Oncol. 2017 Feb;115(2):122-130. doi: 10.1002/jso.24489. Epub 2017 Jan 5.

PMID:
28054348
31.

Predicting which patients actually receive radiation following breast conserving therapy in Canadian populations.

Guidolin K, Lock M, Richard L, Boldt G, Brackstone M.

Can J Surg. 2016 Sep;59(5):358-60.

32.

The Microbiota of Breast Tissue and Its Association with Breast Cancer.

Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G.

Appl Environ Microbiol. 2016 Jul 29;82(16):5039-48. doi: 10.1128/AEM.01235-16. Print 2016 Aug 15.

33.

A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy.

Cecchini MJ, Yu E, Yaremko BP, Boldt RG, Potvin K, Sexton T, D'Souza D, Brackstone M, Lock M.

Cureus. 2016 Apr 3;8(4):e555. doi: 10.7759/cureus.555.

34.

Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.

Hannouf MB, Winquist E, Mahmud SM, Brackstone M, Sarma S, Rodrigues G, Rogan P, Hoch JS, Zaric GS.

Pharmacogenomics J. 2017 Jun;17(3):286-300. doi: 10.1038/tpj.2015.94. Epub 2016 Mar 29.

PMID:
27019982
35.

Longitudinal control behaviour: Analysis and modelling based on experimental surveys in Italy and the UK.

Pariota L, Bifulco GN, Galante F, Montella A, Brackstone M.

Accid Anal Prev. 2016 Apr;89:74-87. doi: 10.1016/j.aap.2016.01.007. Epub 2016 Jan 30.

36.

Daily Incision Cleansing with Alcohol Reduces the Rate of Surgical Site Infections: A Pilot Study.

Vogt KN, Chadi S, Parry N, Gray D, Brackstone M.

Am Surg. 2015 Nov;81(11):1182-6.

PMID:
26672591
37.

Response to: "Current definition of locally advanced breast cancer".

Brackstone M.

Curr Oncol. 2015 Oct;22(5):e411. doi: 10.3747/co.22.2808. No abstract available.

38.

CJS debate: Is mammography useful in average-risk screening for breast cancer?

Brackstone M, Latosinsky S, Saettler E, George R.

Can J Surg. 2016 Feb;59(1):62-6.

39.

Negative pressure wound therapy use to decrease surgical nosocomial events in colorectal resections (NEPTUNE): study protocol for a randomized controlled trial.

Chadi SA, Vogt KN, Knowles S, Murphy PB, Van Koughnett JA, Brackstone M, Ott MC.

Trials. 2015 Jul 30;16:322. doi: 10.1186/s13063-015-0817-8.

40.

Role of plasma osteopontin as a biomarker in locally advanced breast cancer.

Anborgh PH, Caria LB, Chambers AF, Tuck AB, Stitt LW, Brackstone M.

Am J Transl Res. 2015 Apr 15;7(4):723-32. eCollection 2015.

41.

Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Brackstone M, Fletcher GG, Dayes IS, Madarnas Y, SenGupta SK, Verma S; Members of the Breast Cancer Disease Site Group.

Curr Oncol. 2015 Mar;22(Suppl 1):S54-66. doi: 10.3747/co.22.2316.

42.

A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyond.

Simmons CE, Hogeveen S, Leonard R, Rajmohan Y, Han D, Wong A, Lee J, Brackstone M, Boileau JF, Dinniwell R, Gandhi S.

Curr Oncol. 2015 Mar;22(Suppl 1):S43-53. doi: 10.3747/co.22.2328.

43.

Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.

Kim CS, Hannouf MB, Sarma S, Rodrigues GB, Rogan PK, Mahmud SM, Winquist E, Brackstone M, Zaric GS.

Acta Oncol. 2015 Nov;54(10):1781-7. doi: 10.3109/0284186X.2015.1020965. Epub 2015 Mar 31.

PMID:
25825957
44.

Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?

Mandilaras V, Bouganim N, Spayne J, Dent R, Arnaout A, Boileau JF, Brackstone M, Meterissian S, Clemons M.

Curr Oncol. 2015 Feb;22(1):25-32. doi: 10.3747/co.21.2043. Review.

45.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A.

J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.

PMID:
25452445
46.
47.

Cysteine rhenium colloid: a novel radiocolloid for identifying sentinel lymph nodes in breast cancer surgery.

Kidane B, Zabel PL, Gupta V, Whiston C, Wright F, Brackstone M.

Clin Breast Cancer. 2015 Feb;15(1):e41-5. doi: 10.1016/j.clbc.2014.07.006. Epub 2014 Aug 15.

48.

Incisional negative pressure wound therapy decreases the frequency of postoperative perineal surgical site infections: a cohort study.

Chadi SA, Kidane B, Britto K, Brackstone M, Ott MC.

Dis Colon Rectum. 2014 Aug;57(8):999-1006. doi: 10.1097/DCR.0000000000000161.

PMID:
25003295
49.

An acute care surgery service expedites the treatment of emergency colorectal cancer: a retrospective case-control study.

Anantha RV, Brackstone M, Parry N, Leslie K.

World J Emerg Surg. 2014 Mar 21;9(1):19. doi: 10.1186/1749-7922-9-19.

50.

Microbiota of human breast tissue.

Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, Scott L, O'Hanlon DM, Burton JP, Francis KP, Tangney M, Reid G.

Appl Environ Microbiol. 2014 May;80(10):3007-14. doi: 10.1128/AEM.00242-14. Epub 2014 Mar 7.

Supplemental Content

Loading ...
Support Center